Company Name, Symbol, Share
- Abbott Laboratories' (NYSE:ABT) - $56.80 -1.30 (-2.24%)
- AstraZeneca (NYSE:AZN) - $37.96 -0.76 (-1.96%)
- Bristol-Myers Squibb (NYSE:BMY) - $23.07 -0.27 (-1.16%)
- Eli Lilly & Co. (NYSE:LLY) - $50.23 -0.99 (-1.93%)
- GlaxoSmithKline(NYSE:GSK) - $42.16 -0.23 (-0.54)
- Merck & Co. (NYSE:MRK) - $44.53 -1.17 (-2.56%)
- Novartis AG (NYSE:NVS) - $48.95 -0.17 (-0.35%)
- Pfizer Inc. ( NYSE:PFE) - $22.30 -0.37 (-1.63%)
- sanofi-aventis (EPA: SAN) -$51.69 -0.50 (-0.96%)
All pharma stocks are down from last week but GlaxoSmithKline with a decrease of $4.25 and AstraZeneca down $3.29 were the hardest hit.
GSK is down as the Avandia crisis caused a big hit on their bottom line. AZN is down over the experts listing it as a "sell" stock due to the risk that revenues will be severely effected by the launching of generic version of both Nexium and Seroquel.
Comment Preview